
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 15, 2023, titled "NATCO s VIZAG FORMULATION FACILITY RECEIVES ESTABLISHMENT INSPECTION REPORT (EIR)".
Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 15, 2023, titled "NATCO s VIZAG FORMULATION FACILITY RECEIVES ESTABLISHMENT INSPECTION REPORT (EIR)".
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma